The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment.
By A. Greenhough, H. Smartt, A. E. Moore, Heather R. Roberts, A. Williams, C. Paraskeva, Abderrahmane Kaidi. Carcinogenesis, 2009
1,223 citations recorded by the source corpus.
Subfields: Biochemistry, Cancer Research, Pharmacology
View Paper: https://www.semanticscholar.org/paper/a61575a0df446518580b01f04d2939ea9567531f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Jianhua He
- A. Muhammed
- Liang Chen
- J. Deng
- M. Najafi
- Bagher Farhood
- D. Xiao
- Eniseh Salehi
Citations in the corpus
- Differential Macrophage Programming in the Tumor Microenvironment (2012, neutral): “Whether this repolarization is important for therapeutic efficacy of COX-2 inhibitors is unknown however, as PGE2 has pleiotropic effects on multiple aspects of tumor development [108].”
- Anti-Inflammatory Action and Mechanisms of Resveratrol (2021, background): “Prostanoids produced via COX-1 exert renal homeostasis, cytoprotective, immunomodulatory, and platelet function [56], while those derived from COX-2 participates in the inflammatory response [57].”
- Cyclooxygenase‐2 in cancer: A review (2018, background): “(5) Maintenance of cancer stem cell (CSC)‐like activity via activation of WNT/β‐catenin/TCF (Greenhough et al., 2009) and miR526b (Majumder et al., 2015), and suppression of dual specificity phosphatase 2 (Hou et al., 2017).”